```json
{
"content": [
{
"type": "paragraph",
"content": "North America leads the global Nimesulide market with a 35% share, driven by high adoption of advanced pain management therapies and robust R&D investments. The region’s aging population and strong healthcare infrastructure further fuel demand, supported by favorable reimbursement policies."
},
{
"type": "paragraph",
"content": "Europe follows with 30% market share, propelled by stringent regulatory frameworks ensuring drug safety and a mature pharmaceutical ecosystem. Demographic shifts toward chronic disease prevalence and cross-border collaborations in clinical trials reinforce regional growth."
},
{
"type": "paragraph",
"content": The Asia Pacific region is the fastest-growing, expanding at a CAGR of 8.5%, fueled by rising healthcare accessibility, a growing middle-class population, and government investments in pharmaceutical manufacturing. Infrastructure upgrades and partnerships with global players are accelerating ecosystem maturity."
},
{
"type": "paragraph",
"content": Latin America (7% share) and the Middle East & Africa (3% share) exhibit steady Nimesulide market growth due to improving healthcare systems and increasing awareness of non-opioid analgesics. However, policy inconsistencies and underdeveloped supply chains remain barriers to faster adoption."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 30 },
{ "name": "Asia Pacific", "value": 25 },
{ "name": "Latin America", "value": 7 },
{ "name": "Middle East & Africa", "value": 3 }
]
}
}
```
